Strong YoY growth masked by QoQ softness, margin pressure; diversification strategy real but early-stage
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 7/10
Grade B
Q1 numbers aligned with stated targets (+19.2%, +15% guidance). Margin miss (17.9% vs 18-21%) and QoQ softness were not highlighted, suggesting mixed transparency.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
NRB delivered robust Q1 YoY growth (+19.2% revenue, +15.1% PAT) and launched an ambitious, funded diversification strategy (₹270 capex, MTR/Unitec/Corvette wins). But near-term is fragile: QoQ declined (revenue -0.7%, PAT -10.3%), OPM fell to 17.9% (below 18-21% target), and input cost headwinds (electricity, logistics, petroleum) are mounting. Execution risk on nascent verticals (aerospace, defense, data centers) is elevated; most order books are small relative to targets.
₹369.5 Cr
Revenue · +19.2% YoY₹37.8 Cr
Reported PAT · +15.1% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
Revenue ₹370 Cr, profit ₹38 Cr, +19.2% YoY growth
METDelivered ₹369.5 Cr revenue, ₹37.8 Cr PAT, +19.2% YoY, +15.1% PAT YoY
Standalone PAT +31.7% YoY, EBITDA +21.7% YoY
METStandalone growth significantly outpaced consolidated (+15% PAT), confirming strong core business but portfolio drag
Margins between 18-20% targeted
MISSDelivered OPM 17.9%, NPM 10.1%; at low end of 18-21% prior guidance, below target
Strong momentum in Q1
OVERSTATEDYoY +19.2% but QoQ revenue -0.7%, PAT -10.3%; sequential softness despite annual strength
Cost management via VAVE and price increases
METOther expenses rose ₹10 crores (electricity, logistics, petroleum); management offsetting but headwinds evident
Earnings quality
What changed since the last call
Capex guidance
UpgradeRaised from ₹120 Cr (prior) to ₹270 Cr total; ₹60 Cr spent, ₹100 Cr ordered; rule: ₹100 capex → ₹130 sales
Nominated business pipeline
UpgradeIncreased from ₹800 Cr (prior) to ₹1,100 Cr; driven by GM Corvette (300k volume/year) + other automotive adjacency wins
Long-term revenue target
NeutralPrior ₹2,500 Cr by 2031; now 14.38% 12M CAGR extrapolates to ₹2,730 Cr. Management called ₹2,500 'too low', offered ₹3,000 as 'aspirational' but refused formal upgrade
EBITDA margin guidance
NeutralReaffirmed 18-20% on annual basis (prior 18-21%); Q1 came at 17.9%, management said cyclical, expects recovery
Cost headwinds
DowngradeOther expenses up ₹10 Cr QoQ to ₹102 Cr; electricity, logistics, petroleum-driven. Management using VAVE and price hikes to offset.
The Q&A
Analysts pressed hard on growth guidance (Varun Jain asked for ₹3,000 crore confirmation), capex justification (Apoorv queried ₹250→₹270 jump), and defense revenue timing (Shreya, Saloni sought specifics). Management deflected on near-term numbers, citing conservatism and annual vs quarterly guidance preference. Tone was confident but evasive on formal commitments, signaling reluctance to over-promise given execution risk on new ventures.
FY27 growth trajectory — Varun Jain, Dolat Capital
DodgedDeclined to commit. Cited 14.38% trailing 12-month CAGR → ₹2,730 Cr by 2031. Said ₹2,500 'too low', ₹3,000 'aspirational', prefers annual updates to avoid confusion.
Unitec JV capex & location — Varun Jain, Dolat Capital
AnsweredApril 2027 commissioning. ₹110 Cr investment (not capex), ₹130 Cr capacity. Moved location Hyderabad → Aurangabad for logistics/cost reasons; purchased partly ready facility to meet timeline.
Industrial segment path — Rajveer Singh, Vivek Investments
AnsweredIndustrial 14%, grew 34% YoY, up from 11% in prior years. Track only annually, not quarterly, due to seasonal variation.
EV bearing content — Rajveer Singh, Vivek Investments
PartialEV-agnostic strategy; 70% in applications common to ICE/hybrid/EV (chassis, transmission, steering). No pure-EV concentration risk. Refused to quantify bearing content delta.
Defense aerospace order book — Shreya, Serene Alpha
PartialMTR aerospace order book ₹25-30 Cr (later ₹30 + ₹20 regular defense = ₹50 total). Projected ₹300 Cr revenue, ₹90 Cr profit by 2031. FY27 'hard to predict'; Sukhoi-30 spherical bearing order is breakthrough (few global competitors).
Defense order book clarification — Saloni, Molecule Ventures
DodgedSeparated MTR aerospace (₹30) from regular defense (₹20) = ₹50 total. Prior guidance conflated verticals.
Data center market entry — Saloni, Molecule Ventures
PartialData center is NRB (not JV) initiative, still in R&D. Will announce when ready. Acknowledged opportunity is huge; competitors already entered.
Guidance growth rate mismatch — Saloni, Molecule Ventures
DodgedPrefer to be conservative. Use 12-month baseline (14.38% CAGR) to extrapolate; if that rate holds → ₹2,730 Cr. ₹2,500 'too low', ₹3,000 'aspirational'. Will give full update annually, not quarterly, to avoid confusion.
SNL Bearings merger — Sunil, Investor
AnsweredNo concrete merger plans. SNL has proprietary tech, own brand, serves price-sensitive segment. Allows NRB to focus on bigger things. SNL growing aggressively.
Other expenses spike — Shreyans, SG Securities
AnsweredElectricity, logistics, petroleum cost escalation. Offsetting with VAVE (value engineering) and price increases; all three levers in play simultaneously.
Capex progress — Apoorv, Whitestone Financial
AnsweredTotal ₹270 Cr (not ₹250). ₹60 Cr already spent, ₹100 Cr ordered/in process. Rule: ₹100 capex → ₹130 sales.
Margin sustainability — Samarth, Investor
AnsweredMargins 18-20% on annual basis (not quarterly). Time lags, cost escalations happen; must be flexible. Business model by design yields profitable engineering outcomes. Not a quarterly driver.
Mahant Tool talent retention — Samarth, Investor
AnsweredYes. Mr. Mallappa now leads aerospace-defense segment, integrated into NRB supply chain. Acquisition was partly to give him resources to scale dreams.
Lifetime nominated business — Varun Jain, Dolat Capital (follow-up)
AnsweredYes, increased ₹800 → ₹1,100 Cr. GM Corvette alone (300k peak volume/year) plus other wins drove jump. Land + partially ready building already purchased in Shendra (Aurangabad) for April 2027 commissioning.
Robotics/humanoid products — Rajveer Singh, Vivek Investments (follow-up)
AnsweredNRB makes 4,000 products, customized solutions provider. Works with OEMs on design; offers bearings + precision components tailored to their robots. No off-the-shelf; all engineered.
Guidance
FY27: No explicit target given. 12-month CAGR 14.38% → ₹2,730 Cr by 2031.
LowManagement refused quarterly/annual FY27 commitment; deflected to trailing 12M extrapolation. Implies ~15-16% FY27 growth at best if annualized.
FY31: ₹2,500 Cr (prior), ₹2,730 Cr (12M extrapolated), ₹3,000 Cr (aspirational).
MediumCalled ₹2,500 'too low'; won't formally raise to avoid quarterly confusion. Effective guidance is ₹2,730-3,000 range.
EBITDA 18-20% on annual basis (prior 18-21%).
MediumQ1 delivered 17.9% OPM, below range. Management reframed as cyclical, seasonal variation between quarters.
Margin improvement via structural action, capacity expansion, diversification.
MediumNew verticals (aerospace, EV, industrial, defense) positioned as higher-margin. But execution risk is elevated; most nascent.
Total ₹270 Cr over medium term (raised from ₹120 Cr/year).
High₹60 Cr spent, ₹100 Cr ordered/in process, ₹110 Cr for Unitec JV. Rule: ₹100 capex → ₹130 sales.
Unitec JV ₹110 Cr investment, ₹130 Cr capacity, April 2027 commissioning.
HighLand purchased, partially ready building. Moved Hyderabad → Aurangabad for logistics/cost optimization.
Risks the call surfaced
Input cost inflation
MediumOther expenses jumped ₹10 Cr (₹92 → ₹102) this quarter. Management offsetting with VAVE and price hikes, but if input costs accelerate faster, margins will compress below 18-20% target.
Execution risk on diversification
HighMTR aerospace order book ₹25-30 Cr despite ₹300 Cr revenue target by 2031 (10x gap). Data center in R&D. Robotics/humanoid nascent. GM Corvette hasn't started production. If ramp is slower than assumed, FY31 ₹2,730-3,000 Cr target will miss.
Sequential momentum loss
MediumQ1 sequential decline signals either strong prior-quarter comp, seasonality, or momentum loss. If Q2 also declines QoQ, narrative of 'strong momentum' will erode. Not highlighted in opening remarks; transparency concern.
Consolidated vs standalone divergence
LowNRB core (standalone) is outperforming; subsidiaries (SNL, MTR if already consolidated, others) are dragging. If subsidiary integration fails or SNL growth slows, overall group CAGR target will miss.
Guidance opacity / execution uncertainty
MediumAnalysts pressed on ₹3,000 Cr FY31 target (vs ₹2,500 Cr prior); management refused to formally raise, citing conservatism. This signals lack of confidence in near-term delivery or unwillingness to over-promise. Evasion on FY27 guidance also flags uncertainty.
Management
Score 7/10. Confident on strategy and market positioning; evasive on near-term financial commitments. Transparent on segment details (industrial 14%, EV-agnostic 70%) but deflected on formal guidance raises. Q&A showed willingness to engage but preference for annual vs quarterly updates suggests opacity risk. Track record solid on Q1 targets (revenue/PAT matched stated numbers, +19.2% YoY growth on track). Capex raised mid-call (₹120 → ₹270) shows ambition but also lack of forward planning clarity. Margin miss (17.9% vs 18-21% target) not prominently flagged; transparency gap.
1 · April 2027
Unitec JV industrial gearbox facility commissioned; ₹110 Cr investment, ₹130 Cr capacity
2 · 2027
BMW i steering launch; common across ICE/hybrid/EV, validates diversification thesis
3 · Q2–Q3 FY27
GM Corvette production ramp; US manufacturing facility first win, 300k peak volume potential
Execution risk on nascent verticals (aerospace, defense, data centers) is elevated; most order books are small relative to targets.
Informational and educational content only. Not investment advice.